Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Tasosartan
Introduction
Overview
Overview
Tasosartan is an angiotensin II receptor antagonist.
It was withdrawn from FDA review by the manufacturer after phase III clinical trials showed elevated transaminases (a sign of possible liver toxicity) in a significant number of participants given the drug.[1][2]
References
References
- ↑ Atkinson AJ; et al. (2007). Principles of clinical pharmacology. Amsterdam: Elsevier. p. 515. ISBN 0-12-369417-5.
- ↑ Dina R, Jafari M (July 2000). “Angiotensin II-receptor antagonists: an overview”. Am J Health Syst Pharm. 57 (13): 1231–41. PMID 10902066.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]